Cramer’s SELL BLOCK (MAY 3, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Cramer made too many calls on the SELL BLOCK on CNBC’s MAD MONEY tonight, but here are some of his calls:

Hansen Medical (HNSN) is one that he said he’s be a pig not to recommend taking profits up $6.00, but Cramer said he’s going to focus on his losers:

Vulcan Materials (VMC) is one he thought would have a great quarter and it didn’t.  Back then it was at $67 and then he said he would buy more over $100.00 but now it is off $8.00 and should be sold.

P&G (PG) is one that didn’t do well and it hasn’t integrated Gillette, he’d sell.

Allergan (AGN) is one he’s been touting but he didn’t anticipate that Medicis (MRX) would get FDA approval to compete. He still likes Allergan and you aren’t down, but he’d take some off the table because of competitors.

On Medco Health (MHS), they beat estimates but Cramer got in at the top and he said they sold off.

As far as Charter Communications (CHTR), he had the game plan wrong on the set-up, but he thinks its going higher.  He’d stick with it.

Andersones (ANDE) is one he liked but they didn’t guide way up so it fell, he’d get out.

Estee Lauder (EL) benefitted from foreign sales but they did horrible here in the US.

Celgene (CELG) is one he isn’t sure about as far as if he got anything wrong on even though it sold off, but he’s bringing on the CEO for an interview.  Cramer thought the earnings were good, but it sold off.  Here are the CEO comments: "Strong top-line, investing up, thought it was well executed with a building ahead. They will launch in 30 countries for Revlimid and also got Phase III great data in new myeloma patients.  As far as ASCO next month, the company will present more detailed data on myeloma for Revlimid but also for other tumors.  $2.1 Billion cash and company can execute plans on their own and they don’t need to be acquired or even buy anyone."  Cramer said he thinks this is a "Back up the truck" and buy into the weakness ahead of ASCO conference next month.

Jon C. Ogg
May 3, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618